The Optimal Targeting for Focused Ultrasound Thalamotomy Differs between Dystonic and Essential Tremor: A 12‐Month Prospective Pilot Study
Nico Golfrè Andreasi, Arianna Braccia, Vincenzo Levi, Sara Rinaldo, Francesco Ghielmetti, Roberto Cilia, Luigi Romito, Salvatore Bonvegna, Antonio Emanuele Elia, Grazia Devigili, Roberta Telese, Fabiana Colucci, Maria Grazia Bruzzone, Giuseppe Messina, M Corradi, Mario Stanziano, Valentina Caldiera, Sara Prioni, Paolo Amami, M. Poli, Sylvie Piacentini, Marina Grisoli, Elisa Ciceri, Francesco DiMeco, Roberto Eleopra
Abstract
BACKGROUND: Magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy is increasingly used to treat drug-resistant essential tremor (ET). Data on MRgFUS thalamotomy in dystonic tremor (DT) are anecdotal. OBJECTIVES: To investigate efficacy, safety, and differences in target coordinates of MRgFUS thalamotomy in DT versus ET. METHODS: Ten patients with DT and 35 with ET who consecutively underwent MRgFUS thalamotomy were followed for 12 months. Although in both groups the initial surgical planning coordinates corresponded to the ventralis intermediate (Vim), the final target could be modified intraoperatively based on clinical response. RESULTS: Tremor significantly improved in both groups. The thalamic lesion was significantly more anterior in DT than ET. Considering both ET and DT groups, the more anterior the lesion, the lower the odds ratio for adverse events. CONCLUSIONS: MRgFUS thalamotomy is safe and effective in DT and ET. Compared to classical Vim coordinates used for ET, more anterior targeting should be considered for DT.